The protein abundance of SAMD5 in clinical breast cancer and paired non-tumor tissues was assessed using immunohistochemistry (IHC); as shown in Figure 5C, SAMD5 levels were remarkably lower in breast carcinoma samples. This evidence concerns the gene SAMD5 and breast cancer.